504 Stock Overview
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Landfar Bio-medicine Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.84 |
| 52 Week High | CN¥13.17 |
| 52 Week Low | CN¥5.26 |
| Beta | 0.56 |
| 1 Month Change | -26.05% |
| 3 Month Change | -31.12% |
| 1 Year Change | -44.03% |
| 3 Year Change | -52.23% |
| 5 Year Change | -41.19% |
| Change since IPO | 257.14% |
Recent News & Updates
Landfar Bio-medicine Co., Ltd's (SZSE:000504) Popularity With Investors Under Threat As Stock Sinks 32%
Apr 17
Landfar Bio-medicine Co., Ltd (SZSE:000504) Investors Are Less Pessimistic Than Expected
Mar 01Shareholder Returns
| 504 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -5.7% | -1.6% | -0.4% |
| 1Y | -44.0% | -24.8% | -14.4% |
Price Volatility
| 504 volatility | |
|---|---|
| 504 Average Weekly Movement | 12.1% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 000504's share price has been volatile over the past 3 months.
Volatility Over Time: 000504's weekly volatility has increased from 7% to 12% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 512 | Changqiao You | www.landfar.cn |
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. The company operates through Biomedicine, and Energy Saving and Environmental Protection segments. The Biomedicine segment engages in the provision of stem cell storage and technical services; stem cell therapy research; medical device procurement and sales, etc. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business.
Landfar Bio-medicine Co., Ltd Fundamentals Summary
| 504 fundamental statistics | |
|---|---|
| Market cap | CN¥2.26b |
| Earnings (TTM) | -CN¥12.75m |
| Revenue (TTM) | CN¥148.70m |
15.2x
P/S Ratio-177.1x
P/E RatioIs 504 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 504 income statement (TTM) | |
|---|---|
| Revenue | CN¥148.70m |
| Cost of Revenue | CN¥46.60m |
| Gross Profit | CN¥102.10m |
| Other Expenses | CN¥114.85m |
| Earnings | -CN¥12.75m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | -0.039 |
| Gross Margin | 68.66% |
| Net Profit Margin | -8.57% |
| Debt/Equity Ratio | 235.1% |
How did 504 perform over the long term?
See historical performance and comparison